A multistage antimalarial targets the plasmepsins IX and X essential for invasion and egress

Science. 2017 Oct 27;358(6362):522-528. doi: 10.1126/science.aaf8675.

Abstract

Regulated exocytosis by secretory organelles is important for malaria parasite invasion and egress. Many parasite effector proteins, including perforins, adhesins, and proteases, are extensively proteolytically processed both pre- and postexocytosis. Here we report the multistage antiplasmodial activity of the aspartic protease inhibitor hydroxyl-ethyl-amine-based scaffold compound 49c. This scaffold inhibits the preexocytosis processing of several secreted rhoptry and microneme proteins by targeting the corresponding maturases plasmepsins IX (PMIX) and X (PMX), respectively. Conditional excision of PMIX revealed its crucial role in invasion, and recombinantly active PMIX and PMX cleave egress and invasion factors in a 49c-sensitive manner.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antimalarials / chemistry
  • Antimalarials / pharmacology*
  • Antimalarials / therapeutic use
  • Aspartic Acid Endopeptidases / antagonists & inhibitors*
  • Disease Models, Animal
  • Erythrocytes / parasitology
  • Ethylamines / chemistry
  • Ethylamines / pharmacology*
  • Liver / drug effects
  • Liver / parasitology
  • Malaria, Falciparum / drug therapy
  • Malaria, Falciparum / parasitology
  • Malaria, Falciparum / transmission
  • Mice
  • Plasmodium falciparum / drug effects*
  • Plasmodium falciparum / enzymology
  • Plasmodium falciparum / genetics
  • Plasmodium falciparum / pathogenicity

Substances

  • Antimalarials
  • Ethylamines
  • Aspartic Acid Endopeptidases
  • plasmepsin